Zoledronic Acid Injection, Solution
Product Images NDC 67457-794

3 FDA label images from Mylan Institutional Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 67457-794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Stucture (Image 01)

Stucture (Image 01)
Chemical structure diagram of zoledronic acid, showing its characteristic nitrogen-containing heterocyclic ring and phosphonic acid groups, consistent with the active ingredient zoledronic acid in the injection product by Mylan Institutional LLC.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
Two bar graphs compare Zoledronic Acid Injection and Risedronate over time. The first graph shows Therapeutic Response Rate (%) increasing from day 10 to 182, with Zoledronic Acid consistently higher. The second graph shows Serum Alkaline Phosphatase (SAP) Normalization Rate (%) increasing similarly. Both graphs include statistical significance markers (P < 0.001) for Zoledronic Acid at several time points.*
FDA Label Image

Pouch Label (Image 03)

Pouch Label (Image 03)
Zoledronic Acid injection solution, 5 mg per 100 mL (0.05 mg per mL), in a 100 mL vial for intravenous infusion. The label states it is a single-dose solution, sterile, and manufactured by Mylan Institutional LLC. The product NDC is 67457-794, and the label includes usage instructions and dispensing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.